Skip to main content

Research Repository

Advanced Search

Dr CHRISTOPHER COLEMAN's Outputs (3)

Severe acute respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion tethering through a novel mechanism of glycosylation interference (2015)
Journal Article
Taylor, J. K., Coleman, C. M., Postel, S., Sisk, J. M., Bernbaum, J. G., Venkataraman, T., Sundberg, E. J., & Frieman, M. B. (2015). Severe acute respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion tethering through a novel mechanism of glycosylation interference. Journal of Virology, 89(23), 11820-11833. https://doi.org/10.1128/JVI.02274-15

© 2015, American Society for Microbiology. Severe acute respiratory syndrome (SARS) emerged in November 2002 as a case of atypical pneumonia in China, and the causative agent of SARS was identified to be a novel coronavirus, severe acute respiratory... Read More about Severe acute respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion tethering through a novel mechanism of glycosylation interference.

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection (2015)
Journal Article
Pascal, K. E., Coleman, C. M., Mujica, A. O., Kamat, V., Badithe, A., Fairhurst, J., Hunt, C., Strein, J., Berrebi, A., Sisk, J. M., Matthews, K. L., Babb, R., Chen, G., Lai, K.-M. V., Huang, T. T., Olson, W., Yancopoulos, G. D., Stahl, N., Frieman, M. B., & Kyratsous, C. A. (2015). Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences, 112(28), 8738-8743. https://doi.org/10.1073/pnas.1510830112

© 2015, National Academy of Sciences. All rights reserved. Traditional approaches to antimicrobial drug development are poorly suited to combatting the emergence of novel pathogens. Additionally, the lack of small animal models for these infections h... Read More about Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.

Growth and quantification of MERS-CoV infection (2015)
Journal Article
Coleman, C. M., & Frieman, M. B. (2015). Growth and quantification of MERS-CoV infection. Current Protocols in Microbiology, 37(1), 15E.2.1-15E.2.9. https://doi.org/10.1002/9780471729259.mc15e02s37

© 2015 by John Wiley & Sons, Inc. Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging highly pathogenic respiratory virus. Although MERS-CoV only emerged in 2012, we and others have developed assays to grow and quantify infectiou... Read More about Growth and quantification of MERS-CoV infection.